C4 Therapeutics, Inc. Income Taxes Paid
C4 Therapeutics, Inc. (CCCC) reported Income Taxes Paid of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-27.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaid · last filed 2025-02-27
- C4 Therapeutics, Inc. income taxes paid for the quarter ending 2024-12-31 was $0.00.
- C4 Therapeutics, Inc. income taxes paid for the quarter ending 2023-12-31 was $0.00.
- C4 Therapeutics, Inc. income taxes paid for the quarter ending 2022-12-31 was $0.00.
- C4 Therapeutics, Inc. income taxes paid for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- C4 Therapeutics, Inc. income taxes paid for fiscal 2023 was $1.00M.
- C4 Therapeutics, Inc. income taxes paid for fiscal 2022 was $0.00.
- C4 Therapeutics, Inc. income taxes paid for fiscal 2020 was $143.00K, a 86.86% decline from fiscal 2019.
| Period end | Income Taxes Paid 3 month | Income Taxes Paid 9 month | Income Taxes Paid 12 month |
|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $0.00 10-K · filed 2025-02-27 | |
| 2024-09-30 | $0.00 10-Q · filed 2024-10-31 | ||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $1.00M 10-K · filed 2025-02-27 | |
| 2023-09-30 | $1.00M 10-Q · filed 2024-10-31 | ||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $0.00 10-K · filed 2024-02-22 | |
| 2022-09-30 | $0.00 10-Q · filed 2023-11-01 | ||
| 2020-12-31 | $143.00K 10-K · filed 2022-02-24 | ||
| 2019-12-31 | $1.09M 10-K · filed 2022-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |